Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3

NCT02227823 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Spinal Muscular Atrophy Type 3

Interventions

DRUG: Pyridostigmine Bromide

Sponsor

Centre Hospitalier Régional de la Citadelle